VEITH 2024 Conference

Varithena’s versatility and highlights from the Network Meta-Analysis

VEITH 2024 conference

Headshot of Dr. Lowell.

Lowell Kabnick, MD
Chancellor, Vein and Lymphatic University
Far Hills, NJ

Headshot of Keith Sterling

Keith Sterling, MD
Senior Medical Director
Boston Scientific

Watch Dr. Keith Sterling’s discussion with Dr. Lowell Kabnick on Varithena’s effectiveness. Discover key highlights from the Network Meta-Analysis, a study led by Dr. Lowell Kabnick, featuring the first and only Varithena comparative data with long-term endpoints extending up to 6 years​.

Varithena Network Meta-Analysis

The first and only Varithena comparative data with long-term endpoints going out 6 years.